Hematologic Malignancies

• FDA label_change · 2015-03-13
  FDA Approved: KEPIVANCE — Supplemental Application (Swedish Orphan Biovitrum AB (publ))

  FDA approved a supplemental labeling change for Kepivance (palifermin) submitted by Swedish Orphan Biovitrum AB (publ).

• FDA label_change · 2013-05-30
  FDA Approved: KEPIVANCE — Supplemental Application (Swedish Orphan Biovitrum AB (publ))

  FDA approved a supplemental application for Kepivance (palifermin) to update the labeling related to mucositis prevention in patients with h…